NRX Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.62-$3.84 |
Market Cap | $73.4M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $1.2M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $720,000 |
Diluted EPS | -$1.34 |
News
See moreYahoo Finance • 7 days ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Yahoo Finance • 20 days ago
NRx Pharmaceuticals Q4 Earnings Call Highlights
Yahoo Finance • 20 days ago
NRx Pharmaceuticals Wraps Virtual Annual Meeting, Eyes Pivotal 2025 Earnings Call Ahead
Yahoo Finance • 23 days ago
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
About
CEO | Dr. Jonathan C. Javitt M.D., M.P.H. |
CFO | Mr. Michael S. Abrams M.B.A. |
Address | 1201 Orange Street, Wilmington, DE, United States, 19801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |
